Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000-Reference-Cited by-同舟云学术

Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000

Published:2003-03 Issue:3 Volume:25 Page:1017-1038
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

O'Brien Judith A.,Patrick Amanda R.,Caro Jaime

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference90 articles.

1. Diabetes Surveillance,1991

2. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis;Harris;Diabetes Care,1992

3. Symposium: Diabetes update. New developments in pathophysiology and treatment of NIDDM;Chiasson,1995

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of using oral magnesium supplementation in the treatment of prediabetes;Primary Care Diabetes;2022-06

2. Screening for Diabetes Complications during the COVID-19 Outbreak in South Korea;International Journal of Environmental Research and Public Health;2022-04-29

3. Cost–effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetes;Journal of Comparative Effectiveness Research;2021-10

4. Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China;Diabetes Therapy;2020-11-18

5. Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus;Journal of Managed Care & Specialty Pharmacy;2019-10